Neptune Technologies & Bioressources Inc. – Trademark Portfolio

Entity Type: 03

Neptune Technologies & Bioressources Inc. holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 7 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 2 Nice Classification classes. The owner is based in Laval, Quebec.

545 Promenade du Centropolis, Suite 100

Laval, Quebec H7T0A3 , CA

9 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

OCEANO³
OCEANO³
Cancelled 2016
NKO BEAT
NKO BEAT
Cancelled 2013
NKO FLEX
NKO FLEX
Cancelled 2013
NLK
NLK
Cancelled 2003
NLK
NLK
Cancelled 2003
NEPTUNE
NEPTUNE
Abandoned 2003
NKO
NKO
Cancelled 2003
NKO
NKO
Cancelled 2003

Trademark Classifications

Neptune Technologies & Bioressources Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (7 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

1
Chemicals (2 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does Neptune Technologies & Bioressources Inc. have?

Neptune Technologies & Bioressources Inc. has 9 U.S. trademarks filed with the USPTO.

What trademark classes does Neptune Technologies & Bioressources Inc. file in?

Neptune Technologies & Bioressources Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What is Neptune Technologies & Bioressources Inc.'s trademark registration success rate?

Neptune Technologies & Bioressources Inc. has a 0% trademark registration rate, with 0 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.